Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biodesix Inc
(NQ:
BDSX
)
1.370
+0.040 (+3.01%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Biodesix Inc
< Previous
1
2
3
4
Next >
Biodesix Announces Third Quarter 2024 Results and Highlights
November 01, 2024
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix to Participate in Three Investor Conferences in November
October 29, 2024
From
Biodesix, Inc.
Via
GlobeNewswire
Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024
October 18, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study
October 07, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present at Two Investor Conferences in September
September 05, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Second Quarter 2024 Results and Highlights
August 07, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present at Canaccord Genuity’s 44th Annual Growth Conference
August 06, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024
July 24, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix Named to Inc. Magazine’s 2024 “Best Workplaces”
June 18, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Participate in Two Investor Conferences in June
May 28, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting
May 21, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management
May 08, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
May 07, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
April 24, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
April 09, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
April 05, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
March 25, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
March 01, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference
February 26, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
February 16, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method
November 14, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Participate in Two Upcoming Investor Conferences in November
November 09, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Third Quarter 2023 Results and Highlights
November 07, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023
October 24, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting
October 03, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer
September 07, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Participate in Two Upcoming Investor Conferences in September
September 05, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer
August 22, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Second Quarter 2023 Results and Highlights
August 07, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Participate in the Canaccord Genuity 43rd Annual Growth Conference
August 01, 2023
From
Biodesix, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.